ATR
AptarGroup, Inc.
AptarGroup (ATR) Q2 2026 earnings
Published Jul 30, 2026
AI summary
- Revenue $1.03B, up 6.3% from $966M a year ago.
- Adjusted EPS $1.42 beat the $1.35 consensus by $0.07, down from $1.68 a year ago.
- Reported sales grew 6% to over $1 billion for the first time, while core sales increased 1%.
- Reported net income was $88 million, with reported earnings per share of $1.36.
- Pharma, Beauty, and Closures segments all achieved revenue growth during the quarter.
Results vs analyst consensus
Revenue
Reported
$1.03B
Consensus not captured before release
+6.3% YoY
Adjusted EPS
Reported · Adjusted earnings per share
$1.42
Consensus $1.35
Beat by $0.07GAAP EPS: $1.36
Consensus: Yahoo Finance · Q2 2026 · EPS estimate at release
Revenue display rounded; difference uses exact result.
Next quarter outlook
$1.45–$1.53
Q3 2026 EPS guidance (non-GAAP)
Next-quarter consensus not captured before release.
What to watch
- Adjusted EBITDA margins declined across all segments due to product mix, operational factors, and volume changes.
- Results were impacted by short-term headwinds including emergency medicine destocking and new production line ramps.
Read original report
Source: AptarGroup, Inc. press release · SEC Form 8-K exhibit 99.1